Institutional Ownership Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX). We have compiled data on the 323 institutions that hold shares in the stock, with a total of 139 Million shares, which have been reported (via 13F filing form) to have a value of $4.17 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
14,691,344
shares
|
$441 Million
0.25% of portfolio
|
Q2 2025
Added 24.87%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
11,997,085
shares
|
$360 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.39%
|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
11,965,991
shares
|
$359 Million
8.5% of portfolio
|
Q2 2025
Reduced 1.83%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,939,846
shares
|
$298 Million
0.02% of portfolio
|
Q2 2024
Added 4.49%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
6,001,124
shares
|
$180 Million
0.12% of portfolio
|
Q2 2025
Added 122.04%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,954,804
shares
|
$149 Million
0.03% of portfolio
|
Q2 2025
Reduced 22.79%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,942,235
shares
|
$148 Million
0.01% of portfolio
|
Q2 2025
Added 12.13%
|
|
Capital Research Global Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
4,771,786
shares
|
$143 Million
0.03% of portfolio
|
Q2 2025
Reduced 21.9%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,372,837
shares
|
$101 Million
5.12% of portfolio
|
Q2 2025
Added 98.81%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
3,170,247
shares
|
$95.1 Million
0.01% of portfolio
|
Q2 2025
Reduced 10.5%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
3,088,450
shares
|
$92.7 Million
0.08% of portfolio
|
Q2 2025
Added 255.86%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
3,071,588
shares
|
$92.1 Million
11.93% of portfolio
|
Q2 2025
Reduced 4.01%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
3,011,140
shares
|
$90.3 Million
0.01% of portfolio
|
Q2 2025
Added 4.95%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
2,155,137
shares
|
$64.7 Million
0.42% of portfolio
|
Q1 2025
Reduced 16.04%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
2,150,000
shares
|
$64.5 Million
2.48% of portfolio
|
Q2 2025
Added 186.67%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,019,057
shares
|
$60.6 Million
32.11% of portfolio
|
Q4 2022
Reduced 51.57%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,900,179
shares
|
$57 Million
0.01% of portfolio
|
Q1 2025
Added 9.48%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,480,747
shares
|
$44.4 Million
0.09% of portfolio
|
Q2 2023
Added 120.98%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
1,417,711
shares
|
$42.5 Million
0.01% of portfolio
|
Q2 2025
Added 6.32%
|
|
Jennison Associates LLC
|
Aug 01, 2025 Q2 2025 |
1,399,299
shares
|
$42 Million
0.03% of portfolio
|
Q2 2025
Added 24.3%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,380,853
shares
|
$41.4 Million
0.01% of portfolio
|
Q2 2025
Added 27.81%
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Aug 14, 2025 Q2 2025 |
1,310,605
shares
|
$39.3 Million
0.73% of portfolio
|
Q2 2025
Added 8.49%
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
1,305,125
shares
|
$39.2 Million
40.07% of portfolio
|
Q2 2025
Added 83.63%
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,298,514
shares
|
$39 Million
4.25% of portfolio
|
Q2 2025
Added 133.1%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
1,175,661
shares
|
$35.3 Million
0.04% of portfolio
|
Q2 2025
Added 11.9%
|